Nasal spray could shrink polyps and reduce need for surgery
NCT ID NCT07675512
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study tests whether a nasal spray containing adelmidrol can reduce inflammation and shrink nasal polyps in people with chronic sinusitis. Participants are adults aged 18 to 70 who are scheduled for sinus surgery. Half receive standard care plus the adelmidrol spray, while the other half receive standard care alone. The study measures polyp size, symptoms, and whether the spray improves recovery after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- adelmidrol nasal spray
- What this could lead to
- If it works, this could offer a new way to control nasal polyps and reduce the need for surgery in some patients.
- What could go wrong
- This is a small, early-stage study. The results may not apply to everyone, and the spray may not work better than standard treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants must meet all of the following criteria to be eligible for enrollment: * Male or female patients aged 18 to 70 years. * Diagnosis of chronic rhinosinusitis with nasal polyps (CRSwNP) requiring surgical treatment. * Presence of nasal polyps confirmed by clinical examination and nasal endoscopy. * Candidates for Functional Endoscopic Sinus Surgery (FESS) for removal of one or more nasal polyps. * Ability and willingness to comply with study procedures, treatment regimen, follow-up visits, and assessments. * Ability to provide written informed consent. * No treatment with antihistamines during the previous 6 months. * No ongoing treatment with topical or systemic corticosteroids at the time of enrollment. Exclusion Criteria: * Chronic maxillary sinusitis without nasal polyps. * Previous endoscopic sinonasal surgery within the preceding 12 months. * Current treatment with systemic antihistamines. * Current treatment with topical or systemic corticosteroids. * Diagnosis of asthma. * History of radiotherapy to the head and neck region within the previous 3 years. * Current or recent (within the previous 3 years) treatment for any form of cancer. * Presence of a serious neurological disorder that could interfere with study participation or outcome assessment. * Known immunodeficiency, including but not limited to Acquired Immunodeficiency Syndrome (AIDS). * Acute purulent sinusitis associated with fever requiring antibiotic therapy. * Requirement for systemic antibiotic treatment at enrollment. * Current treatment with oral anticoagulants (e.g., warfarin). * Any medical condition that, in the investigator's judgment, may compromise patient safety, adherence to the protocol, or interpretation of study results. * Development of fever or a bacterial infection requiring antibiotic therapy during the follow-up period; such patients will be withdrawn from the study after enrollment according to the protocol.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic sinusitis with nasal polyps are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ospedale di Fano, Dipartimento di Otorinolaringoiatria
Fano, Italy